Journal: The EMBO Journal
Article Title: A unified mechanism for mitochondrial damage sensing in PINK1-Parkin–mediated mitophagy
doi: 10.1038/s44318-025-00604-z
Figure Lengend Snippet: ( A ) Schematic illustrating the core glycolysis pathway with screen hits in red and inhibitors tested in black. ( B ) Flow cytometry measurements in HeLa MFN2-Halo+mCh-Parkin cells (top), HeLa mt-Keima (middle), and HeLa PINK1-YFP (bottom) treated with CCCP 10 µM for 4 h, illustrating similar results between PINK1 and ENO1 sgRNA. **** P ≤ 0.0001 by Brown–Forsythe and Welch ANOVA tests with Dunnett’s T3 multiple comparisons test (exact P values top graph—CTRL vs ENO1, P = 6.07e-09; CTRL vs PINK1, P = 2.17e-07; exact P values middle graph—CTRL vs ENO1, P = 4.55e-05; CTRL vs PINK1, P = 2.56e-08; exact P values bottom graph—CTRL vs ENO1, P = 3.26e-09; CTRL vs PINK1, P = 6.46e-09). Error bars mean +/− SD. N = 6 independent experiments from two separate transductions. ( C ) Representative immunoblots of PINK1 stabilization and activity in HeLa dCas9-BFP-ZIM3 cells with indicated glycolytic enzyme sgRNA treated with 10 µM CCCP + /− 10 mM 2-DG for 4 h. N = 3 independent experiments. ( D ) Representative immunoblots of PINK1 stabilization and activity in HeLa dCas9-BFP-ZIM3 cells treated with 10 µM CCCP, 10 µM HA, 10 mM 2-DG, and/or 50 µg/mL CHX for 4 h. N = 3 independent experiments. ( E ) Representative confocal image of i 3 Neurons immunostained for neuronal markers. Scale bar = 10 µm. ( F ) Representative immunoblot of lysates from i 3 Neurons, treated with 10 mM 2-DG, 10 µM HA, and/or 20 µM CCCP, with or without insulin withheld, probing for PINK1 stabilization and activity. *Denotes non-specific band. MFN2-ub1 = monoubiquitinated MFN2. N ≥ 6 total replicates from at least two independent differentiations. ( G ) Immunoblot SUNset assay (bottom) performed in HeLa PINK-YFP cells as indicated in the scheme (top), demonstrating block in overall translation and loss of PINK1 accumulation in the presence of 10 µM CCCP and 10 mM 2-DG for 4 h. Puro puromycylated proteins. N = 3 independent experiments. ( H ) Immunoblot of HeLa dCas9-BFP-ZIM3 cells illustrating cleaved PINK1 (PINK1-c) abundance, stabilized by proteasome inhibition (50 µM MG132), following inhibition of mitochondrial ATP (10 µg/mL oligomycin) and/or glycolytic ATP (10 mM 2-DG) production for 4 h. N = 3 replicates on at least two occasions. ( I ) Flow cytometry measurements of PINK1-YFP (left graph) and mitochondrial membrane potential with TMRE 20 nM (right graph), following drug treatment for 4 h. Graphs are representative of N = 3 independent experiments. ( J ) Immunoblot of HeLa dCas9-BFP-ZIM3 cells treated with escalating doses of CCCP with or without F 1 F O -ATP synthase inhibition (oligomycin 10 µg/mL) for 4 h, probing PINK1 stabilization and activation. Import block of ATP5A is monitored through the accumulation of uncleaved ATP5A (ATP5A-p) relative to mature ATP5A (ATP5A-m). N = 3 independent experiments. .
Article Snippet: Dual sgRNA CRISPRi Library 1–2 , Addgene , 187246.
Techniques: Flow Cytometry, Western Blot, Activity Assay, Blocking Assay, Inhibition, Membrane, Activation Assay